Cardiovascular co-morbidity in rheumatic diseases

References

• AnkerSDCoatsAJHow to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACHInt J Cardiol2002861233012419548
   PubMed Web of Science ®Google Scholar
• BengtssonAARylanderLHagmarLRisk factors for developing systemic lupus erythematosus: a case-control study in southern SwedenRheumatology (Oxford)2002415637112011382
   PubMed Web of Science ®Google Scholar
• BondSFarewellVTSchentagCTReporting of mortality in a psoriatic arthritis clinic is primarily a function of the number of clinic contacts and not disease severityJ Rheumatol2005322364716331765
   PubMed Web of Science ®Google Scholar
• BootsJMChristiaansMHvan HoofJPEffect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular riskDrugs20046420477315341497
   PubMed Web of Science ®Google Scholar
• BrylEVallejoANMattesonELModulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritisArthritis Rheum2005522996300316200579
   PubMedGoogle Scholar
• BrånenLHovgaardLNitulescuMInhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout miceArterioscler Thromb Vasc Biol20042421374215345516
   PubMed Web of Science ®Google Scholar
• CarmonaLDescalzoMAPerez-PampinEAll-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonistsAnn Rheum Dis2007668808517324968
   PubMed Web of Science ®Google Scholar
• CannonCPCurtisSPFitzGeraldGACardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparisonLancet200636817718117113426
   PubMed Web of Science ®Google Scholar
• ChogleARChakravartyACardiovascular events in systemic lupus erythematosus and rheumatoid arthritis: Emerging concepts, early diagnosis and managementJ Assoc Physicians India200755324017444342
   PubMedGoogle Scholar
• ChoiHKHernanMASeegerJDMethotrexate and mortality in patients with rheumatoid arthritis: a prospective studyLancet20023591173711955534
   PubMed Web of Science ®Google Scholar
• ConroyRMPyröläKFitzgeraldAPEstimation of 10-year risk of fatal cardiovascular disease in Europe: the SCORE projectEur Heart J200324987100312788299
   PubMed Web of Science ®Google Scholar
• DavisJMIIIMaradit-KremersHGabrielSUse of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?J Rheumatol20053218566216206334
   PubMed Web of Science ®Google Scholar
• DavisJMIIIMaradit-KremersHCrowsonCSGlucocorticoids and cardiovascular events in rheumatoid arthritisArthritis Rheum2007568203017330254
   PubMed Web of Science ®Google Scholar
• Del RinconIWilliamsKSternMPAssociation between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjectsArthritis Rheum20034818334012847676
   PubMed Web of Science ®Google Scholar
• DivechaHSattarNRumleyACardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammationClin Sci (Lond)2005109171615801904
   PubMed Web of Science ®Google Scholar
• DixonWGSymmonsDPMWhat effects might anti-TNF[alpha] therapy be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNF[alpha] in cardiovascular pathophysiologyAnn Rheum Dis20076611323617251223
   PubMed Web of Science ®Google Scholar
• DoriaAIaccardinoLGhirardelloALong-term prognosis and causes of death in systemic lupus erythematosusAm J Med2006119700616887417
   PubMed Web of Science ®Google Scholar
• EichnerERExercise and arthritis. The hematology of inactivityRheum Dis Clin North Am199016815252087578
   PubMedGoogle Scholar
• EscalanteAHaasRWdel RinconIParadoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammationArch Intern Med20051651624916043681
   PubMedGoogle Scholar
• EsdaileJMAbrahamowiczMGrodzickyTTraditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosusArthritis Rheum2001442331711665973
   PubMed Web of Science ®Google Scholar
• FrancoOHde LaetCPeetersAEffects of physical activity on life expectancy with cardiovascular diseaseArch Intern Med200516523556016287764
   PubMed Web of Science ®Google Scholar
• FriesJFSpitzPWYoungDYThe dimensions of health outcomes: the health assessment questionnaire, disability and pain scalesJ Rheumatol19829789937175852
   PubMed Web of Science ®Google Scholar
• GabrielSECrowsonCSKremersHMSurvival in rheumatoid arthritis: a population- based analysis of trends over 40 yearsArthritis Rheum20034854812528103
   PubMed Web of Science ®Google Scholar
• GerliRSchillaciGGiordanoACD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patientsCirculation20041092744815159291
   PubMed Web of Science ®Google Scholar
• GoodsonNJSymmonsDPMScottDGBaseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohortArthritis Rheum2005522293916052597
   PubMed Web of Science ®Google Scholar
• Gonzales-JuanateyCLlorcaJAmigo-DiazEHigh prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factorsArthritis Rheum20075710748017665475
   PubMedGoogle Scholar
• GordonM-MThomsonEAMadhokRCan intervention modify adverse lifestyle variables in a rheumatoid population? Results of a pilot studyAnn Rheum Dis20026166911779763
   PubMed Web of Science ®Google Scholar
• HaaraMMManninenPKrogerHOsteoarthritis of finger joints in Finns aged 30 or over: prevalence, determinants, and association with mortalityAnn Rheum Dis200362151812525385
   PubMed Web of Science ®Google Scholar
• HanssonGKInflammation, atherosclerosis, and coronary artery diseaseN Engl J Med200535216859515843671
   PubMed Web of Science ®Google Scholar
• HollanIScottHSatvedtKInflammatory rheumatic disease and smoking are predictors of aortic inflammation: a controlled study of biopsy specimens obtained at coronary artery surgeryArthritis Rheum2007562072917530648
   PubMed Web of Science ®Google Scholar
• HootmanJMMaceraCASamHAPhysical activity levels among the general US adult population and in adults with and without arthritisArthritis Rheum2003491293512579604
   PubMed Web of Science ®Google Scholar
• HootmanJMHelmickCGProjections of US prevalence of arthritis and associated activity limitationsArthritis Rheum200654226916385518
   PubMed Web of Science ®Google Scholar
• JacobssonLTKnowlerWCPillemerSRheumatoid arthritis and mortality. A longitudinal study in Pima IndiansArthritis Rheum1993361045538343181
   PubMed Web of Science ®Google Scholar
• JacobssonLTTuressonCKnowlerWCNumber of swollen joints predicts cardiovascular death; results from a population study of Pima IndiansArthritis Rheum20014411707611352251
   PubMedGoogle Scholar
• JacobssonLTTuressonCGülfeALow incidence of first cardiovascular event in rheumatoid arthritis patients treated with TNF-blockersJ Rheumatol20053212131815996054
   PubMed Web of Science ®Google Scholar
• JacobssonLTHTuressonCNilssonJ-ÅTreatment with TNF-blockers and mortality risk in patients with rheumatoid arthritisAnn Rheum Dis200766670517158824
   PubMed Web of Science ®Google Scholar
• KearneyPMBaigentCGodwinJDo selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ20063321302816740558
   PubMed Web of Science ®Google Scholar
• KipenYBrigantiEMStraussBJThree-year follow-up of body composition in pre-menopausal women with systemic lupus erythematosusRheumatology (Oxford)199938596510334684
   PubMedGoogle Scholar
• KremersHMNicolaPJCrowsonCSPrognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritisArthritis Rheum2004503450715529378
   PubMed Web of Science ®Google Scholar
• KumedaYInabaMGotoHIncreased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritisArthritis Rheum20024614899712115178
   PubMed Web of Science ®Google Scholar
• LakkaTASalonenJTModerate to high intensity conditioning leisure time physical activity and high cardiorespiratory fitness are associated with reduced plasma fibrinogen in eastern Finnish menJ Clin Epidemiol1993461119278410097
   PubMed Web of Science ®Google Scholar
• LehtinenKMortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitisAnn Rheum Dis19935217468484668
   PubMed Web of Science ®Google Scholar
• LiTYRanaJSMansonJEObesity as compared with physical activity in predicting risk of coronary heart disease in womenCirculation200611349950616449729
   PubMed Web of Science ®Google Scholar
• LiangKPLiangKVMattesonELIncidence of noncardiac vascular disease in rheumatoid arthritis and relationship to extra-articular disease manifestationsArthritis Rheum200654642816447212
   PubMed Web of Science ®Google Scholar
• LiuzzoGKopeckySLFryeRLPerturbation of the T-cell repertoire in patients with unstable anginaCirculation19991002135910571971
   PubMed Web of Science ®Google Scholar
• LiuzzoGGoronzyJJYangHMonoclonal T-cell proliferation and plaque instability in acute coronary syndromesCirculation20001012883810869258
   PubMed Web of Science ®Google Scholar
• ManziSMeliahnENRairieJEAge-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham StudyAm J Epidemiol1997145408159048514
   PubMed Web of Science ®Google Scholar
• ManziSSelzerFSutton-TyrrellKPrevalence and risk factors of carotid plaque in women with systemic lupus erythematosusArthritis Rheum19994251609920014
   PubMed Web of Science ®Google Scholar
• Maradit-KremersHMNicolaPJCrowsonCSCardiovascular death in rheumatoid arthritis: a population-based studyArthritis Rheum2005527223215751097
   PubMed Web of Science ®Google Scholar
• McCareyDWMcInnesIBMadhokRTrial of atorvastatin in rheumatoid arthritis (TARA): double blind, placebo-controlled trialLancet200436320152115207950
   PubMed Web of Science ®Google Scholar
• McEntegartACapellHACreranDCardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritisRheumatology (Oxford)200140640411426020
   PubMed Web of Science ®Google Scholar
• MichelJJTuressonCLemsterBCD56-expressing T cells that have senescent features are expanded in rheumatoid arthritisArthritis Rheum200756435717195207
   PubMedGoogle Scholar
• MinorMALaneNERecreational exercise in arthritisRheum Dis Clin North Am199622563778844914
   PubMed Web of Science ®Google Scholar
• PalinskiWNapoliCUnraveling pleiotropic effects of statins on plaque ruptureArterioscler Thromb Vasc Biol20022217455012426197
   PubMed Web of Science ®Google Scholar
• ParkWWeyandCMSchmidtDCo-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cellsEur J Immunol1997271082909174596
   PubMed Web of Science ®Google Scholar
• ParkYBLeeSKLeeWKLipid profiles in untreated patients with rheumatoid arthritisJ Rheumatol1999261701410451065
   PubMed Web of Science ®Google Scholar
• PetersMJvan der Horst-BruinsmaIEDijkmansBACardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritisSemin Arthritis Rheum2004345859215609262
   PubMed Web of Science ®Google Scholar
• PetriMKianiANPostWLupus atherosclerosis prevention study (LAPS): Randomized double blind placebo controlled trial of atorvastatin versus placeboArthritis Rheum200654S520
   Google Scholar
• PhilbinEFRiesMDGroffGDOsteoarthritis as a determinant of an adverse coronary heart disease risk profileJ Cardiovasc Risk19963529339100089
   PubMedGoogle Scholar
• Rantapää-DahlqvistSWållberg-JonssonSDahlénGLipoprotein (a), lipids, and lipoproteins in patients with rheumatoid arthritisAnn Rheum Dis19915036681829348
   PubMed Web of Science ®Google Scholar
• RidkerPMWilsonPWGrundySMShould C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?Circulation200410928182515197153
   PubMed Web of Science ®Google Scholar
• RidkerPMCannonCPMorrowDC-reactive protein levels and outcomes after statin therapyN Eng J Med2005352208
   PubMed Web of Science ®Google Scholar
• RizelloVLiuzzoGBrugatellaSModulation of CD4(+)CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable anginaCirculation20061132272716682617
   PubMed Web of Science ®Google Scholar
• RomanMJSchankerBADavisAPrevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosusN Engl J Med2003349239940614681505
   PubMed Web of Science ®Google Scholar
• RossRAtherosclerosis – an inflammatory diseaseN Engl J Med1999340115269887164
   PubMed Web of Science ®Google Scholar
• SattarNMcInnesIBVascular comorbidity in rheumatoid arthritis: potential mechanisms and solutionsCurr Opin Rheumatol2005172869215838238
   PubMed Web of Science ®Google Scholar
• SattarNMcCareyDWCapellHExplaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritisCirculation200310829576314676136
   PubMed Web of Science ®Google Scholar
• SchererYShoenfeldYMechanisms of disease: atherosclerosis in autoimmune diseasesNat Clin Pract Rheumatol,200629910616932663
   PubMedGoogle Scholar
• SchmidtDMartensPBWeyandCMThe repertoire of CD4+ CD28− T cells in rheumatoid arthritisMol Med19962608188898376
   PubMed Web of Science ®Google Scholar
• SilmanANewmanJMacGregorAJCigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twinsArthritis Rheum19963973258639169
   PubMed Web of Science ®Google Scholar
• SilmanAJHochbergMCEpidemiology of the rheumatic diseases1993OxfordOxford University Press
   Google Scholar
• SolomonDHKarlsonEWRimmEBCardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritisCirculation20031071303712628952
   PubMed Web of Science ®Google Scholar
• SolomonDHSchneeweissSGlynnRJRelationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adultsCirculation200410920687315096449
   PubMed Web of Science ®Google Scholar
• SolomonDHCurhanGCRimmEBCardiovascular risk factors in women with and without rheumatoid arthritisArthritis Rheum2004503444915529391
   PubMed Web of Science ®Google Scholar
• SolomonDHAvornJStürmerTCardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugsArthritis Rheum20065413788916645966
   PubMed Web of Science ®Google Scholar
• SolomonDHSturmerTGlynnRJNSAIDs, coxibs, and cardiovascular outcomes: Exploratory subgroup analysesArthritis Rheum200654S335
   Google Scholar
• SvenungssonEJensen-UrstadKHeimbürgerMRisk factors for cardiovascular disease in systemic lupus erythematosusCirculation200110418879311602489
   PubMed Web of Science ®Google Scholar
• TaylorPCAnti-TNF alpha therapy for rheumatoid arthritis: an updateIntern Med200342152012583612
   PubMed Web of Science ®Google Scholar
• TolozaSMUribeAGMcGwinGJrSystemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular eventsArthritis Rheum20045039475715593203
   PubMed Web of Science ®Google Scholar
• TuressonCEndothelial expression of MHC class II molecules in autoimmune diseaseCurr Pharm Des2004101294314754393
   PubMed Web of Science ®Google Scholar
• TuressonCJarenrosAJacobssonLTIncreased incidence of cardiovascular disease in patients with rheumatoid arthritis – results from a community based studyAnn Rheum Dis200463952515051620
   PubMed Web of Science ®Google Scholar
• TuressonCMcClellandRLChristiansonTJSevere extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritisAnn Rheum Dis200766596416901955
   PubMed Web of Science ®Google Scholar
• TuressonCMattesonELCardiovascular risk factors, fitness and physical activity in rheumatic diseasesCurr Opin Rheumatol200719190617278937
   PubMed Web of Science ®Google Scholar
• VallbrachtKBSchwimmbeckPLSeebergBEndothelial dysfunction of peripheral arteries in patients with immunohistologically confirmed myocardial inflammation correlates with endothelial expression of human leukocyte antigens and adhesion molecules in myocardial biopsiesJ Am Coll Cardiol2002405152012142120
   PubMed Web of Science ®Google Scholar
• van DoornumSMcCollGWicksIPAtorvastatin reduces arterial stiffness in patients with rheumatoid arthritisAnn Rheum Dis20046315717515547080
   PubMed Web of Science ®Google Scholar
• van DoornumSJenningsGLRWicksIPReducing the cardiovascular disease burden in rheumatoid arthritisMed J Aust20061842879016548834
   PubMed Web of Science ®Google Scholar
• WatsonDJRhodesTGuessHAAll-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research DatabaseJ Rheumatol200330119620212784389
   PubMed Web of Science ®Google Scholar
• WajedDAhmadYDurringtonPNPrevention of cardiovascular disease in systemic lupus erythematosus. Proposed guidelines for risk factor managementRheumatology (Oxford)20044371212867578
   PubMed Web of Science ®Google Scholar
• WarburtonDENicolCWBredinSSPrescribing exercise as preventive therapyCMAJ20061749617416567757
   PubMed Web of Science ®Google Scholar
• WikströmIJacobssonLTChange in and predictors of leisure activities among patients with rheumatoid arthritis: a prospective studyScand J Rheumatol2005343677116296568
   PubMed Web of Science ®Google Scholar
• WilsonPWD’AgostinoRBLevyDPrediction of coronary heart disease using risk factor categoriesCirculation1998971837479603539
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudKGefellerOPredicting mortality in patients with rheumatoid arthritisArthritis Rheum20034815304212794820
   PubMed Web of Science ®Google Scholar
• WolfeFMichaudKHeart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapyAm J Med20041163051114984815
   PubMed Web of Science ®Google Scholar
• WongKGladmanDDHustedJMortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of deathArthritis Rheum1997401868729336423
   PubMed Web of Science ®Google Scholar
• Wållberg-JonssonSÖhmanM-LRantapää-DahlqvistSCardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern SwedenJ Rheumatol199724445519058647
   PubMed Web of Science ®Google Scholar
• Wållberg-JonssonSJohanssonHÖhmanM-LExtent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onsetJ Rheumatol19992625627110606363
   PubMed Web of Science ®Google Scholar
• YoungAKoduriGBatleyMMortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosisRheumatology (Oxford)2007463505916908509
   PubMed Web of Science ®Google Scholar
• YusufSHawkenSOunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet20043649375215364185
   PubMed Web of Science ®Google Scholar